Usted buscó: in comparison to the register in patients t... (Danés - Portugués)

l03aa13 reduction in the duration of neutropenia in patients treated with cytotoxic chemotherapy
l03aa13 reduction in the duration of neutropenia in patients

trainees registered in the ecb traineeship programme are subject to the rules governing this programme ( download )
trainees registered in the ecb traineeship programme are subject to the rules governing this programme ( download )

the data in these sheets show that shetland seafish ltd would become profitable and that the turnover is expected to increase in comparison to 2000, with more than 16 % in 2001 and with 26 % in 2002.
the data in these sheets show that shetland seafish ltd would become profitable and that the turnover is expected to increase in comparison to 2000, with more than 16 % in 2001 and with 26 % in 2002.

adjustment for baseline covariates points to consider on the use of statistical methods for flexible design and analysis of confirmatory clinical trials points to consider on clinical pharmacokinetic investigation of the pharmacokinetics of peptides and proteins note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal function points to consider on the evaluation of the pharmacokinetics of medicinal products in the paediatric population note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with hepatic impairment note for guidance on clinical investigation of medicinal products for the treatment of psoriasis points to consider on allergic rhino- conjuctivitis addendum to the note for guidance on modified release oral and transdermal dosage forms:
adjustment for baseline covariates points to consider on the use of statistical methods for flexible design and analysis of confirmatory clinical trials points to consider on clinical pharmacokinetic investigation of the pharmacokinetics of peptides and proteins note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal function points to consider on the evaluation of the pharmacokinetics of medicinal products in the paediatric population note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with hepatic impairment note for guidance on clinical investigation of medicinal products for the treatment of psoriasis points to consider on allergic rhino- conjuctivitis addendum to the note for guidance on modified release oral and transdermal dosage forms:

(1) following informal discussions, by letter of 22 july 2005, registered in the commission on 26 july 2005 under number a/6948, the united kingdom notified to the commission a scheme for increasing the manufacturing capacity of printing and writings paper from recycled fibre under the waste and resources action programme (wrap).
(1) following informal discussions, by letter of 22 july 2005, registered in the commission on 26 july 2005 under number a/6948, the united kingdom notified to the commission a scheme for increasing the manufacturing capacity of printing and writings paper from recycled fibre under the waste and resources action programme (wrap).